Benzinga's Top #PreMarket Gainers

Spectrum Pharmaceuticals SPPI shares gained 13.77% to $7.85 after the company reported that its pivotal trial of Captisol-enabled Melphalan met its primary endpoint. Skyworks Solutions SWKS soared 8.01% to $41.00 in the pre-market trading after the company reported upbeat Q2 results and issued a strong Q3 forecast. Gilead Sciences GILD surged 3.84% to $75.66 in the pre-market session after the company reported better-than-expected first-quarter results and announced strong sales of its hepatitis C drug. Yum! Brands YUM shares jumped 3.24% to $79.99 in pre-market trading after the company reported better-than-expected first-quarter earnings. Yum posted its adjusted net income of $0.87 per share, versus analysts' estimates of $0.84 per share.